El castell de Puig-Reig. Segles IX-XVI
Serra Giménez, Eudald
López Mullor, Albert
Universitat de Lleida. Facultat de Lletres
MetadataShow full item record
The following license files are associated with this item:
Showing items related by title, author, creator and subject.
Budget impact analysis of switching to digital mammography in a population-based breast cancer screening program: a discrete event simulation model Comas, Mercè; Arrospide, Arantzazu; Mar, Javier; Sala i Serra, Maria; Vilaprinyo Terré, Ester; Hernández, Cristina; Cots, Francesc; Martínez, Juan; Castells, Xavier (Public Library of Science, 2014)Objective: To assess the budgetary impact of switching from screen-film mammography to full-field digital mammography in a population-based breast cancer screening program. Methods: A discrete-event simulation model was ...
Impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme Blanch, Jordi; Sala i Serra, Maria; Ibáñez, Josefa; Domingo, Laia; Fernández, Belén; Otegi, Arantza; Barata, Teresa; Zubizarreta, Raquel; Ferrer, Joana; Castells, Xavier; Rué i Monné, Montserrat; Salas, Dolores; Interval Cancer Study Group (Public Library of Science, 2014-10-21)Background: Interval cancers are primary breast cancers diagnosed in women after a negative screening test and before the next screening invitation. Our aim was to evaluate risk factors for interval cancer and their subtypes ...
Tumor phenotype and breast density in distinct categories of interval cancer: results of population-based mammography screening in Spain Domingo, Laia; Salas, Dolores; Zubizarreta, Raquel; Baré, Marisa; Sarriugarte, Garbiñe; Barata, Teresa; Ibáñez, Josefa; Blanch, Jordi; Puig-Vives, Montserrat; Fernández, Ana Belén; Castells, Xavier; Sala i Serra, Maria; Interval Cancer Study Group (BioMed Central, 2014)Introduction: Interval cancers are tumors arising after a negative screening episode and before the next screening invitation. They can be classified into true interval cancers, false-negatives, minimal-sign cancers, and ...